BARC Develops India’s First Ruthenium 106 Plaque For Effective Eye Cancer Treatment

sfg-2026
ForumIAS LATEST
  1. 31 May |Post Prelims Meet with Ayush Sir | Offline Session to discuss the Post-Prelims agenda | ForumIAS Click Here to register for the event →
  2. 02 June |Open Session - The PSIR Mark Improvement by Aman Aloon (AIR 295, UPSC CSE 2025)|Click Here to register for the event →
  3. 04 June | Open Orientation for GSAP 2026| Click Here to register →
  4. 06 June | Open Orientation on Essay Guidance Program (EGP 2026) Click Here to register →
  5. 07 June | Open Orientation for Current Affairs for Mains 2026 Click Here to register →

News: Bhabha Atomic Research Centre(BARC) Mumbai has developed an Eye Cancer therapy. It was the first indigenous Ruthenium 106 Plaque for the treatment of Ocular Tumors.

Facts:

  • Ruthenium-106: It is a radioactive form of the rare heavy metal ruthenium. It is a “platinum group” metal similar to platinum.
  • How is it produced? It is produced from the fission or splitting of uranium-235, the type of uranium used in nuclear fission reactors, so it’s found in spent nuclear fuel.
  • Uses: It is used in medicine for cancer radiation therapy, especially for eye and skin tumors. It is also used in radioisotope thermoelectric generators that power satellites.
  • Harmful to Humans: High doses of ruthenium are toxic and carcinogenic when ingested. The material is strongly retained in the bones.

Article Source

 

 

Print Friendly and PDF
Blog
Academy
Community